6th Annual Stem Cell and Regenerative Medicine Congress

Memo

We will welcome over 150 delegates from from internationally renowned academic institutions global pharmaceutical organisations and leading biotech companies. Over 20 presentations and case studies focusing on the discovery of stem cells in regenerative medicine, manufacturing innovations in clinical trials and bioprocessing methods in cell line development. Including 2 interactive streams: Day 1 | Stem Cell Discovery and Development For Regenerative Medicine Day 2 | Stem Cell Bioprocessing, Manufacturing and Commercialising Strategies Co-located with the established 8th Annual Cell Culture and Bioprocessing Congress and 5th Annual Cell and Gene Therapy Congress. On Tuesday October 29, 2019 at 7:30 am (ends Wednesday October 30, 2019 at 6:00 pm) Price: Registration Available from: GBP 299.0 URLs: Website: https://go.evvnt.com/395616-0?pid=5569 Tickets: https://go.evvnt.com/395616-2?pid=5569 Brochure: https://go.evvnt.com/395616-3?pid=5569 Speakers: Chaim Lebovits, Chief Executive Officer and President, BrainCell Therapeutics, Curtis Rambaran, Senior Director, Daiichi Sankyo, Theresa Deisher, Founder and Managing Member, AVM Biotechnology, Marina Tarunina, Research Director, Plasticell, Bart Vaes, Associate Director, Site leader, Regenesys Venue details: Hotel Novotel London West, Hammersmith International Ctre 1, Shortlands, London, W6 8DR, United Kingdom